CytoMed Therapeutics Limited (GDTC)

CytoMed Therapeutics Revenue

CytoMed Therapeutics had revenue of 224.18K SGD in the half year ending June 30, 2024, with 200.74% growth. This brings the company's revenue in the last twelve months to 447.70K, down -21.95% year-over-year. In the year 2023, CytoMed Therapeutics had annual revenue of 507.74K with 39.52% growth.

• Revenue (ttm): 447.70K SGD
• Revenue Growth: -21.95%
• P/S Ratio: 89.46
• Revenue / Employee: 15,989 SGD
• Employees: 28
• Market Cap: 29.54M USD

Revenue Chart

* This company reports financials in SGD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	507.74K	143.82K	39.52%
Dec 31, 2022	363.91K	250.07K	219.67%
Dec 31, 2021	113.84K	54.37K	91.43%
Dec 31, 2020	59.47K	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.